Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes

Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes

US Patent 6207170 · Granted Mar 27, 2001

Estimated economic value: $6,756,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic cancer vaccine containing tumor-associated neoantigens and immunosti2023
Therapeutic cancer vaccine containing tumor-associated neoantigens and immunosti2023
Sustained release of antiinfectives2017
Platinum aggregates and process for producing the same2015
Sustained release of antiinfectives2014
High delivery rates for lipid based drug formulations, and methods of treatment 2011
Sustained release of antiinfectives2010
Sustained release of antiinfectives2009
Treatment of cancers by inhalation of stable platinum-containing formulations2004
Multilamellar coalescence vesicles (MLCV) containing biologically active compoun2003
Multilamellar coalescence vesicles (MLCV) containing biologically active compoun2003
Multilamellar coalescence vesicles (MLCV) containing biologically active compoun2003